Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189395 · ClinicalTrials.gov registry record · Phase 4
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
A Phase 4 study, sponsored by Riverside University Health System Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
NCT02189395 is a Phase 4 study that was terminated before completion, run by Riverside University Health System Medical Center. The registered enrollment target is 52 participants.
The verdict
NCT02189395, a Phase 4 study, was terminated before completion, sponsored by Riverside University Health System Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
Study Summary
The goal of the current study is to determine difference in glycemic control between traditional split mix regimen with Neutral Protamine Hagedorn (NPH) and regular insulin vs basal bolus regimen with glargine and humalog in a population of type 2 diabetes commonly encountered in the investigators county hospital setting which include newly diagnosed type 2 patients and patients on relatively high dose of insulin (dose \>0.4 units/kg body weight. Primary outcome of the study is to determine differences in glycemic control between treatment group as measured by the mean daily blood glucose. Secondary outcome is to measure number of hypoglycemic events, number of severe hypoglycemia and length of hospital stay.
Interventions
- DRUG NPH and regular insulin
- DRUG glargine and humalog
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189395
The ClinicalTrials.gov registry entry for NCT02189395 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Riverside University Health System Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NPH and regular insulin is the first listed.
NCT02189395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02189395 about?
NCT02189395 is a clinical study titled "Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting". The goal of the current study is to determine difference in glycemic control between traditional split mix regimen with Neutral Protamine Hagedorn (NPH) and regular insulin vs basal bolus regimen with glargine and humalog in a population of type 2 diabetes commonly encountered in the investigators c...
What is the current status of trial NCT02189395?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2013-04. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02189395?
The interventions under investigation include: NPH and regular insulin (DRUG), glargine and humalog (DRUG).
Who is sponsoring clinical trial NCT02189395?
This trial is sponsored by Riverside University Health System Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.